Current therapeutic strategies for DMD mainly rely on two approaches: (1) restoring the expression and/or function of dystrophin using gene-based, cell-based, and protein replacement therapies and (2) improving muscle function and quality by targeting the downstream pathological changes (5, 6). Here, DMD is linked to Duchenne muscular dystrophy.